Bridgebio
IPO News: BridgeBio Pharma Inc. Prices 20.5mm Share IPO at $17, above the $14-$16 Marketing Range
Bridgebio

BridgeBio Pharma Inc

Exchange: NASDAQ

NASDAQ: BBIO

Initial Filing Date: 05/24/19

Launch Date: 06/17/19

Pricing Date 06/26/19

IPO Price: $17.00

Price Range: $14.00 - $16.00

Initial Shares Offered (mm): 15.0

Shares Offered (Pre-Shoe | mm): 20.5

Amount Offered (mm): $348.5

% Secondary: 0.0%

Shares Outstanding (mm): 120.5

Market Value at Pricing (mm): $2,048.5

Offering as % of Market Value: 17.0%

Bookrunners: JPM | GS | JEFF | LEER | KKR | PJ | MIZ | BMO | RJA 

Major Holders: KKR Genetic Disorder LP | Viking Global Opportunities Illiquid Investments | Directors

Industry: Healthcare

Description: BridgeBio Pharma is a team of experience drug discoverers, developers and innovators working to create life-altering medicines that target well-characterized genetic diseases at their source. 

Note: Emerging Growth Company; 5% DSP 

Reference Link: S-1/A